Malú Gámez Tansey
Professor/Co-Director
- Gainesville FL UNITED STATES
- College of Medicine
Malú Gámez Tansey researches how the immune system protects or predisposes us to Alzheimer's, Parkinson's and frontotemporal dementia.
Contact More Open optionsBiography
Malú Gámez Tansey's research mission is to understand how the immune system protects or predisposes us to Alzheimer's, Parkinson's and frontotemporal dementia to enable us to diagnose and prevent these disorders. She is a professor of neuroscience and neurology and co-director of Center for Translational Research in Neurodegenerative Disease in the College of Medicine. The UF Tansey Lab's interests include investigating the role and regulation of neuroinflammatory and immune system responses in modulating the gene-environment interactions that determine risk for development and progression of neurodegenerative and neuropsychiatric disease.
Areas of Expertise
Social
Articles
Inflammation and immune dysfunction in Parkinson disease
Nature Reviews ImmunologyMalú Gámez Tansey, et al.
2022-03-04
Parkinson disease (PD) is a progressive neurodegenerative disease that affects peripheral organs as well as the central nervous system and involves a fundamental role of neuroinflammation in its pathophysiology. Neurohistological and neuroimaging studies support the presence of ongoing and end-stage neuroinflammatory processes in PD.
Addressing the disparities in dementia risk, early detection and care in Latino populations: Highlights from the second Latinos & Alzheimer's Symposium
Alzheimer's & DementiaYakeel T. Quiroz, et al.
2022-02-24
The Alzheimer's Association hosted the second Latinos & Alzheimer's Symposium in May 2021. Due to the COVID-19 pandemic, the meeting was held online over 2 days, with virtual presentations, discussions, mentoring sessions, and posters. The Latino population in the United States is projected to have the steepest increase in Alzheimer's disease (AD) in the next 40 years, compared to other ethnic groups.
Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis
Molecular NerodegenerationKim A. Staats, et al.
2022-01-24
Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disease in which many processes are detected including (neuro)inflammation. Many drugs have been tested for ALS in clinical trials but most have failed to reach their primary endpoints.
